← Evidence map

ArticleNature2023

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Christina Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

88 papers cite itlatest 60 shown

2023
…
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37844613